Company profile: Epimeron
1.1 - Company Overview
Company description
- Provider of gene discovery, deployment, and optimization solutions that support important plant biochemical functions required for maximum product yield.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Epimeron
Lynx Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology diagnostic and therapeutic solutions, including Lynxgen Therapeutics LongSAGE mRNA for mRNA sequence analysis to support precision treatment and diagnostics; globally distributed ELISA kits for detecting biomarkers such as chemokines and COVID-19; and exosome-based methods for diagnostics and therapy addressing antibiotic resistance in Mycoplasma pneumoniae.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lynx Therapeutics company profile →
Clear Labs
HQ: United States
Website
- Description: Provider of biotechnology solutions that integrate a genomics system to simplify diagnostics for the clinical and application sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clear Labs company profile →
Vanadis Diagnostics
HQ: Sweden
Website
- Description: Provider of a novel non-invasive prenatal testing (NIPT) solution in development based on digital analysis of cell-free DNA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vanadis Diagnostics company profile →
Congenica
HQ: United Kingdom
Website
- Description: Provider of a clinical genomic diagnostic decision support platform. Sapientia integrates human DNA sequences with deep clinical phenotyping to enable actionable interpretation. Offerings include automated analysis for inherited diseases, somatic oncology, rare disease diagnosis, pathogen surveillance and pharma insights, upcoming pharmacogenomics, plus professional services for implementation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Congenica company profile →
IDbyDNA
HQ: United States
Website
- Description: Provider of precision metagenomics to uncover the microbial world, aiming to bring the precision seen in cancer care to infectious disease patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDbyDNA company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Epimeron
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Epimeron
2.2 - Growth funds investing in similar companies to Epimeron
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Epimeron
4.2 - Public trading comparable groups for Epimeron
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →